Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities (Q92052398)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 April 2020

Language	Label	Description	Also known as
English	Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities	scientific article published on 19 April 2020

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Maarten Altelaar

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Ricardo Ribas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Nikiana Simigdala

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Eugene Schuster

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Joanna Nikitorowicz-Buniak

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Anna Ressa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Mariana Ferreira Leal

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Amandeep Bhamra

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Allan Thornhill

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Ludivine Morisset

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Elodie Montaudon

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Laura Sourd

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Martin Fitzpatrick

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Stephen R Johnston

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Elisabetta Marangoni

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Lesley-Ann Martin

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

publication date

19 April 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32307447%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Palbociclib and Letrozole in Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PaDuA: A Python Library for High-Throughput (Phospho)proteomics Data Analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Elucidation of Signaling Pathways from Large-Scale Phosphoproteomic Data Using Protein Interaction Networks

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional viability profiles of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The history and future of targeting cyclin-dependent kinases in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin D as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of aromatase inhibition on functional gene modules in estrogen receptor-positive breast cancer and their relationship with antiproliferative response

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinases and pseudokinases: lessons from RAF.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Secrets of a double agent: CDK7 in cell-cycle control and transcription

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting WEE1 Kinase in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MAPK reliance via acquired CDK4/6 inhibitor resistance in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-020-1284-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q92052398&oldid=2234572167"